# Research Idea

## Title
Adaptive Clinical Trial Design via Deep Learning-Predicted Heterogeneous Treatment Effects and Contextual Thompson Sampling

## Motivation
Clinical trials remain prohibitively expensive and slow, with oncology trials particularly challenged by patient heterogeneity in treatment response. Current randomized allocation ignores predictable differences in how patients respond to treatments, wasting resources on suboptimal patient-arm assignments. While adaptive trial designs and heterogeneous treatment effect (HTE) estimation have advanced separately, no framework integrates deep learning-based HTE prediction with adaptive allocation strategies to systematically reduce sample size requirements while maintaining statistical validity.

## Main Idea
We propose an adaptive trial framework where patient allocation is guided by contextual Thompson Sampling informed by predicted individual treatment effects. The causal mechanism operates through four steps: (1) transformer-encoded multi-modal patient embeddings capture treatment-relevant heterogeneity from EHR and molecular profiles; (2) a DR-Learner estimates conditional average treatment effects for each patient; (3) contextual Thompson Sampling allocates patients to arms where they are predicted to respond best; (4) this concentration reduces variance in treatment effect estimation.

We will validate through 1,000 simulated oncology trials across varying effect sizes and heterogeneity levels, comparing against random allocation, stratified randomization, and standard adaptive designs. Primary success criterion: ≥20% reduction in sample size for 80% statistical power. Secondary metrics include HTE estimation accuracy (PEHE) and trial success rates. This framework could accelerate drug development timelines while reducing costs and patient burden.